Trial record 24 of 292 for: Sodium Fluoride OR Duraphat
NUPRO(r) Sensodyne Prophylaxis Paste With NovaMin(r)Sensitivity Relief Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01610167|
Recruitment Status : Completed
First Posted : June 1, 2012
Results First Posted : October 14, 2013
Last Update Posted : October 14, 2013
Information provided by (Responsible Party):
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Triple (Participant, Care Provider, Investigator); Primary Purpose: Treatment|
Device: NUPRO Classic Prophy Paste
Device: NUPRO Sensodyne Prophy Paste with Novamin with fluoride.
Device: NUPRO Sensodyne Prophy Paste with Novamin without fluoride.
|Recruitment Details||327 subjects queried from Investigator database following IRB apprvoal on 14-Sept.-2011. 199 of the queried subjects were consented and screened. 161 subjects were accepted at screening and appointed for baseline visit 2 weeks later. 159 subjects were evaluated at the baseline exam and 151 subjects were randomized and enrolled into the study.|
|Pre-assignment Details||10 subjects were lost following screening and at baseline assessment. 5 of the 10 were disqualified due to insufficient tactile response, 3 due to lack of evaproative hypersensitivity, and 2 had scheduling conflicts.|